Concentration director: Mathieu Lavallee

Concentration director: Emilio Alarcon

This concentration will engage students in solving challenges that confront patients living with cardiovascular diseases. The goal of the cardiovascular medicine concentration is translating fundamental insights into clinical care innovations and practice.

By using a combination of practical work, course work, self-guided learning, and national/international collaborators; the cardiovascular graduate program will engage students in solving challenges that confront our patients living with cardiovascular diseases.

Concentration Director: Natalia Jaworska

Concentration Director: Rebecca Thornhill

About the concentration:

Advances in medical imaging and associated technologies have transformed modern medicine. These advances have transcended diagnostic applications to lead to new therapies in the form of image guided interventions in surgery and radiation oncology, as well as novel applications of artificial intelligence and virtual reality. 

With these advances comes an increase in the numbers and complexity of deployed systems. There will be a need for individuals who can understand these technologies and contribute to research that optimizes their clinical application. 

This proposed concentration in Medical Imaging and Radiation Sciences will bring together technical and clinical experts to enable multidisciplinary research. This concentration is looking for appropriately qualified individuals in clinical research involving medical imaging, radiation-based therapy, and other diagnostic and therapeutic applications of technology. Students would have undergraduate degrees in science (physics, engineering, computer science, chemistry, biology) OR a bachelor’s degree and appropriate clinical expertise as a licensed medical radiation technologist or board certification in an aligned medical discipline including but not limited to diagnostic radiology, nuclear medicine, or radiation oncology.

Concentration Director: Aymeric Ravel-Chapuis

This concentration will encompass both the neuromuscular and musculoskeletal systems.

It will provide an overview of the most common neuromuscular disorders, with a specific focus on diseases such as Duchenne muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, and congenital myasthenic syndromes. Additionally, it will address muscle-wasting conditions caused by cancer cachexia, disuse, and aging, as well as rhabdomyosarcoma. It will explore various therapeutic strategies for these neuromuscular disorders. Graduate students will benefit from the expertise of basic scientists and clinician-scientists from the Eric Poulin Centre for Neuromuscular Disease and Ottawa Neuromuscular Centre.

The musculoskeletal component of this concentration will focus on degenerative conditions affecting joints and tendons. It will cover fundamental principles of joint mechanics, and factors contributing to joint dysfunction and pain. It will also examine post-surgical infections following trauma or joint replacement procedures, with a focus on pathomechanisms and available antibiotic and surgical treatments. Graduate students will have the opportunity to learn from expert clinicians and clinician-scientists from the University of Ottawa Division of Orthopedic Surgery, a leading center in musculoskeletal care.

The MSK concentration welcomes applicants with a BSc or MSc in sciences and an interest in neuromuscular disorders, as well as residents from the orthopedic surgery department.

Concentration Director: Jeffrey Victor Leyton

Pharmaceutical sciences encompass an interdisciplinary field dedicated to the discovery, development, and translation of medications that improve the quality of life. The pharmaceutical sciences concentration integrates chemistry, biology, pharmacology, including recent technological advancements such as artificial intelligence, nanomedicines, and targeted drug delivery. Our researchers investigate diverse pharmaceuticals, such as small molecule drug design, biologics, nanoparticles, drug formulation strategies, and work in cooperation with the school of pharmacy.

Competitive applicants should have a background in life sciences, chemistry, engineering, or computational sciences. The concentration aims to provide students with an environment that enables proficient understanding of the pharmaceutical landscape, from conceptual design, through research and development, and finally to clinical translation. Students completing the Pharmaceutical Sciences concentrations will not only attain an MSc or PhD degree in a focused pharmaceutical research domain, but be well-versed to apply the skills gained in diverse sectors impacted by pharmaceutical sciences. 

Concentration Director: Claudia Malic

Concentration Director: Coming soon

Alexandre Blais

Allison Clouthier

Andrew Tice

Aymeric Ravel-Chapuis

Braden Gammon

Bradley Meulenkamp

Daniel Coutu

Eng Kuan Moo

Eugene Wai

Geoffrey Dervin

Geoffrey Wilkin 

Gerd Melkus

Hanspeter Frei

J Pollock

Jean-Philippe St-Pierre

Joel Werier

Junio Dort

Kevin Smit

Manisha Mistry

Paul Beaule

Peter Lapner

Stephane Poitras

Steven Papp

Teresa Flaxman

Thomas Uchida

Wade Gofton

Andrée-Anne Ledoux

Aroldo Dargél

Georg Northoff

Jeanne Talbot

Jennifer Phillips

Jess Fiedorowicz

Lauri Tuominen

Marco Solmi

Michael Seto

Nicole Obeid

Simon Hatcher

Synthia Guimond

Lana A. Castellucci

Greg Knoll

Stéphane Aris-Brosou

Mathieu Lavallée-Adam

Arvind Mer

We are still working on finalizing details for this concentration which will open on the Fall of 2025, and for this reason the supervisors are not yet available.